Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Kavanagh

Showing results (161-170 of 193) with videos related to

Pageof 20
Sort By:
Frontiers in Immunology|December 27, 2021
Homodimeric Minimal Factor H: <i>In Vivo</i> Tracking and Extended Dosing Studies in Factor H Deficient MiceOla Kamala, Talat H Malik, Thomas M Hallam, et al.
Nature Genetics|September 17, 2013
Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degenerationJohanna M Seddon, Yi Yu, Elizabeth C Miller, et al.
Blood|April 20, 2006
Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcomeJessica Caprioli, Marina Noris, Simona Brioschi, et al.
HRB Open Research|April 15, 2021
The future of genomics in Ireland - focus on genomics for healthCathal Seoighe, Adrian P Bracken, Patrick Buckley, et al.
Annals of Medicine|September 28, 2017
Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: Characterization, ethnic distribution and evolutionary implicationsGregory S Hageman, Lisa S Hancox, Andrew J Taiber, et al.
Lancet (London, England)|September 28, 2025
Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 studyDavid Kavanagh, Andrew S Bomback, Marina Vivarelli, et al.
Stem Cells (Dayton, Ohio)|September 16, 2017
An Induced Pluripotent Stem Cell Patient Specific Model of Complement Factor H (Y402H) Polymorphism Displays Characteristic Features of Age-Related Macular Degeneration and Indicates a Beneficial Role for UV Light ExposureDean Hallam, Joseph Collin, Sanja Bojic, et al.
Annals of Medicine|April 19, 2007
Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implicationsGregory S Hageman, Lisa S Hancox, Andrew J Taiber, et al.
Journal of the American Society of Nephrology : JASN|October 23, 2015
A De Novo Deletion in the Regulators of Complement Activation Cluster Producing a Hybrid Complement Factor H/Complement Factor H-Related 3 Gene in Atypical Hemolytic Uremic SyndromeRachel C Challis, Geisilaine S R Araujo, Edwin K S Wong, et al.
Blood|August 19, 2020
Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working groupFadi Fakhouri, Marie Scully, François Provôt, et al.
Pageof 20

Showing results (161-170 of 193) with videos related to

Sort By:
Pageof 20
Frontiers in Immunology|December 27, 2021
Homodimeric Minimal Factor H: <i>In Vivo</i> Tracking and Extended Dosing Studies in Factor H Deficient MiceOla Kamala, Talat H Malik, Thomas M Hallam, et al.
Nature Genetics|September 17, 2013
Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degenerationJohanna M Seddon, Yi Yu, Elizabeth C Miller, et al.
Blood|April 20, 2006
Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcomeJessica Caprioli, Marina Noris, Simona Brioschi, et al.
HRB Open Research|April 15, 2021
The future of genomics in Ireland - focus on genomics for healthCathal Seoighe, Adrian P Bracken, Patrick Buckley, et al.
Annals of Medicine|September 28, 2017
Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: Characterization, ethnic distribution and evolutionary implicationsGregory S Hageman, Lisa S Hancox, Andrew J Taiber, et al.
Lancet (London, England)|September 28, 2025
Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 studyDavid Kavanagh, Andrew S Bomback, Marina Vivarelli, et al.
Stem Cells (Dayton, Ohio)|September 16, 2017
An Induced Pluripotent Stem Cell Patient Specific Model of Complement Factor H (Y402H) Polymorphism Displays Characteristic Features of Age-Related Macular Degeneration and Indicates a Beneficial Role for UV Light ExposureDean Hallam, Joseph Collin, Sanja Bojic, et al.
Annals of Medicine|April 19, 2007
Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implicationsGregory S Hageman, Lisa S Hancox, Andrew J Taiber, et al.
Journal of the American Society of Nephrology : JASN|October 23, 2015
A De Novo Deletion in the Regulators of Complement Activation Cluster Producing a Hybrid Complement Factor H/Complement Factor H-Related 3 Gene in Atypical Hemolytic Uremic SyndromeRachel C Challis, Geisilaine S R Araujo, Edwin K S Wong, et al.
Blood|August 19, 2020
Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working groupFadi Fakhouri, Marie Scully, François Provôt, et al.
Pageof 20